Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this trial is to evaluate the long-term safety of efgartigimod IV and efgartigimod PH20 SC administered to participants with gMG in the antecedent studies, ARGX-113-2006 and ARGX-113-2207, respectively.
Epistemonikos ID: 4f05602a35b2e3981e6058718825b3b3b8270790
First added on: May 13, 2024